ID: 129935289 | ATAC-STARR-seq lymphoblastoid active region 16881 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (191220785..191220954) | | |
ID: 129935288 | ATAC-STARR-seq lymphoblastoid active region 16880 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (191204601..191204720) | | |
ID: 129660882 | ReSE screen-validated silencer GRCh37_chr2:192406286-192406448 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (191541560..191541722) | | |
ID: 129660881 | ReSE screen-validated silencer GRCh37_chr2:192310324-192310491 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (191445598..191445765) | | |
ID: 129660880 | ReSE screen-validated silencer GRCh37_chr2:192055155-192055352 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (191190429..191190626) | | |
ID: 127275450 | NANOG hESC enhancer GRCh37_chr2:192343668-192344568 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (191478942..191479842) | | |
ID: 127275449 | NANOG hESC enhancer GRCh37_chr2:192320787-192321298 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (191456061..191456572) | | |
ID: 127275448 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr2:192168644-192169562 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (191303918..191304836) | | |
ID: 127275447 | H3K27ac hESC enhancer GRCh37_chr2:192146127-192146627 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (191281401..191281901) | | |
ID: 127275446 | H3K27ac hESC enhancer GRCh37_chr2:192145626-192146126 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (191280900..191281400) | | |
ID: 127275445 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr2:192112141-192112934 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (191247415..191248208) | | |
ID: 127275444 | H3K27ac hESC enhancer GRCh37_chr2:192110016-192110638 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (191245290..191245912) | | |
ID: 126806453 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr2:192428730-192429929 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (191564004..191565203) | | |
ID: 126806452 | BRD4-independent group 4 enhancer GRCh37_chr2:192053185-192054384 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (191188459..191189658) | | |
ID: 124905959 | uncharacterized LOC124905959 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (191615020..191637503) | | |
ID: 122861270 | Sharpr-MPRA regulatory region 1767 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (191256023..191256317) | | |
ID: 122152331 | MYO1B antisense RNA 1 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (191229165..191246175, complement) | | |
ID: 120977017 | Sharpr-MPRA regulatory region 3391 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (191594123..191594417) | | |
ID: 115947632 | CRISPRi-validated cis-regulatory element chr2.5925 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (191597195..191597646) | | |
ID: 112806066 | Sharpr-MPRA regulatory region 10229 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (191377283..191377577) | | |